What's New in Melanoma

Giselle Prado; Ryan M. Svoboda; Darrell S. Rigel

doi:10.1016/j.det.2018.12.005

What's New in Melanoma

Giselle Prado, Ryan M. Svoboda, Darrell S. Rigel

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Abstract

Melanoma is rapidly evolving because of advances in noninvasive diagnosis, targeted therapies, and improved prognostic methods. This article discusses what is new in melanoma risk factors, prevention, clinical management, and targeted treatment. The incidence continues to increase worldwide, whereas mortality is steadily improving. This trend reinforces the importance of dermatologists comprehensively understanding all aspects of melanoma. Further research is needed to continue making a material impact on outcomes for patients.

Original language	English
Pages (from-to)	159-168
Number of pages	10
Journal	Dermatologic Clinics
Volume	37
Issue number	2
DOIs	https://doi.org/10.1016/j.det.2018.12.005
State	Published - Apr 2019
Externally published	Yes

Keywords

Diagnosis
Genomics
Management
Melanoma epidemiology
Prognosis
Risk factors

Access to Document

10.1016/j.det.2018.12.005

Cite this

@article{93a2d129d5854c789334adaf8a77609f,

title = "What's New in Melanoma",

abstract = "Melanoma is rapidly evolving because of advances in noninvasive diagnosis, targeted therapies, and improved prognostic methods. This article discusses what is new in melanoma risk factors, prevention, clinical management, and targeted treatment. The incidence continues to increase worldwide, whereas mortality is steadily improving. This trend reinforces the importance of dermatologists comprehensively understanding all aspects of melanoma. Further research is needed to continue making a material impact on outcomes for patients.",

keywords = "Diagnosis, Genomics, Management, Melanoma epidemiology, Prognosis, Risk factors",

author = "Giselle Prado and Svoboda, {Ryan M.} and Rigel, {Darrell S.}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = apr,

doi = "10.1016/j.det.2018.12.005",

language = "English",

volume = "37",

pages = "159--168",

journal = "Dermatologic Clinics",

issn = "0733-8635",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - What's New in Melanoma

AU - Prado, Giselle

AU - Svoboda, Ryan M.

AU - Rigel, Darrell S.

PY - 2019/4

Y1 - 2019/4

N2 - Melanoma is rapidly evolving because of advances in noninvasive diagnosis, targeted therapies, and improved prognostic methods. This article discusses what is new in melanoma risk factors, prevention, clinical management, and targeted treatment. The incidence continues to increase worldwide, whereas mortality is steadily improving. This trend reinforces the importance of dermatologists comprehensively understanding all aspects of melanoma. Further research is needed to continue making a material impact on outcomes for patients.

AB - Melanoma is rapidly evolving because of advances in noninvasive diagnosis, targeted therapies, and improved prognostic methods. This article discusses what is new in melanoma risk factors, prevention, clinical management, and targeted treatment. The incidence continues to increase worldwide, whereas mortality is steadily improving. This trend reinforces the importance of dermatologists comprehensively understanding all aspects of melanoma. Further research is needed to continue making a material impact on outcomes for patients.

KW - Diagnosis

KW - Genomics

KW - Management

KW - Melanoma epidemiology

KW - Prognosis

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85061374527&partnerID=8YFLogxK

U2 - 10.1016/j.det.2018.12.005

DO - 10.1016/j.det.2018.12.005

M3 - Review article

C2 - 30850038

AN - SCOPUS:85061374527

SN - 0733-8635

VL - 37

SP - 159

EP - 168

JO - Dermatologic Clinics

JF - Dermatologic Clinics

IS - 2

ER -

What's New in Melanoma

Abstract

Keywords

Access to Document

Fingerprint

Cite this